Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis
- DOI
- 10.1007/s10147-026-03129-5
- Published
- 2026-07-31
- Container
- International Journal of Clinical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-026-03129-5,
title = {Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis},
author = {Iwao Sugitani and Naomi Kiyota and Hiroo Imai and Shunji Takahashi and Akihiro Nishiyama and Shingo Tamura and Yasushi Shimizu and Shigenori Kadowaki and Ken-ichi Ito and Yoshinori Hirashima and Shinji Ueno and Teruaki Katayama and Makoto Tahara},
year = {2026},
journal = {International Journal of Clinical Oncology},
doi = {10.1007/s10147-026-03129-5},
url = {https://doi.org/10.1007/s10147-026-03129-5}
}RIS
TY - JOUR TI - Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis AU - Iwao Sugitani AU - Naomi Kiyota AU - Hiroo Imai AU - Shunji Takahashi AU - Akihiro Nishiyama AU - Shingo Tamura AU - Yasushi Shimizu AU - Shigenori Kadowaki AU - Ken-ichi Ito AU - Yoshinori Hirashima AU - Shinji Ueno AU - Teruaki Katayama AU - Makoto Tahara PY - 2026 JO - International Journal of Clinical Oncology DO - 10.1007/s10147-026-03129-5 UR - https://doi.org/10.1007/s10147-026-03129-5 ER -
APA
Sugitani, I., Kiyota, N., Imai, H., Takahashi, S., Nishiyama, A., Tamura, S., Shimizu, Y., Kadowaki, S., Ito, K., Hirashima, Y., Ueno, S., Katayama, T., & Tahara, M. (2026). Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03129-5
Source records
- crossref · retrieved 2026-09-26T09:15:34.139Z